119 related articles for article (PubMed ID: 30038597)
41. Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathologic Characteristics and BRAF Mutation in Papillary Thyroid Cancer.
Wang Q; Yang H; Wu L; Yao J; Meng X; Jiang H; Xiao C; Wu F
Thyroid; 2016 Dec; 26(12):1719-1732. PubMed ID: 27758138
[TBL] [Abstract][Full Text] [Related]
42. Highly expressed long non-coding RNA NNT-AS1 promotes cell proliferation and invasion through Wnt/β-catenin signaling pathway in cervical cancer.
Hua F; Liu S; Zhu L; Ma N; Jiang S; Yang J
Biomed Pharmacother; 2017 Aug; 92():1128-1134. PubMed ID: 28628975
[TBL] [Abstract][Full Text] [Related]
43. BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma.
Wang Y; Guo Q; Zhao Y; Chen J; Wang S; Hu J; Sun Y
Oncol Lett; 2014 Nov; 8(5):1947-1952. PubMed ID: 25289082
[TBL] [Abstract][Full Text] [Related]
44. The Long Non-Coding RNA
Wu S; Ding L; Xu H; Gao J; Shao Y; Zhang S; Wei Z
Onco Targets Ther; 2020; 13():7897-7906. PubMed ID: 32884284
[TBL] [Abstract][Full Text] [Related]
45. The LINC01186 suppresses cell proliferation and invasion ability in papillary thyroid carcinoma.
Wang N; Duan H; Zhang C; Zhou Y; Gao R
Oncol Lett; 2018 Nov; 16(5):5639-5644. PubMed ID: 30344719
[TBL] [Abstract][Full Text] [Related]
46. Long non-coding RNA HNF1A-AS1 promotes cell viability and migration in human bladder cancer.
Feng Z; Wang B
Oncol Lett; 2018 Apr; 15(4):4535-4540. PubMed ID: 29541223
[TBL] [Abstract][Full Text] [Related]
47. The effect of antagonizing RGD-binding integrin activity in papillary thyroid cancer cell lines.
Cheng W; Feng F; Ma C; Wang H
Onco Targets Ther; 2016; 9():1415-23. PubMed ID: 27042110
[TBL] [Abstract][Full Text] [Related]
48. Long non-coding (lnc)RNA PAPAS overexpression inhibits tumor growth in papillary thyroid carcinoma by downregulating lncRNA HOTTIP.
Xiao J; Bing Z; Xiao G; Guan Y; Luan J
Oncol Lett; 2020 Mar; 19(3):2281-2285. PubMed ID: 32194727
[TBL] [Abstract][Full Text] [Related]
49. AUF1 Promotes Proliferation and Invasion of Thyroid Cancer
Du X; Wang JM; Zhang DL; Wu T; Zeng XY; Jiang JY; Du ZX
Front Oncol; 2021; 11():681736. PubMed ID: 34222000
[TBL] [Abstract][Full Text] [Related]
50. Long non-coding RNA Mirt2 interacts with long non-coding RNA IFNG-AS1 to regulate ulcerative colitis.
Li C; Cui L; Li S; Li M; Miao X
Exp Ther Med; 2020 Nov; 20(5):32. PubMed ID: 32952623
[TBL] [Abstract][Full Text] [Related]
51. High expression of HAX-1 protein is associated with tumor growth in papillary thyroid carcinoma.
Wang Y; Xie X; Sun Z; Zang J; Sun X; Peng S; Yu X; Wang X
Int J Clin Exp Pathol; 2018; 11(4):2080-2087. PubMed ID: 31938315
[TBL] [Abstract][Full Text] [Related]
52. LncRNA HOTAIR impairs the prognosis of papillary thyroid cancer via regulating cellular malignancy and epigenetically suppressing DLX1.
Kuo FC; Wang YT; Liu CH; Li YF; Lu CH; Su SC; Liu JS; Li PF; Huang CL; Ho LJ; Lin CM; Lee CH
Cancer Cell Int; 2022 Dec; 22(1):396. PubMed ID: 36494673
[TBL] [Abstract][Full Text] [Related]
53. Next-generation sequence detects
Wang QX; Chen ED; Cai YF; Zhou YL; Zheng ZC; Wang YH; Jin YX; Jin WX; Zhang XH; Wang OC
Onco Targets Ther; 2016; 9():7161-7167. PubMed ID: 27920554
[TBL] [Abstract][Full Text] [Related]
54. Long Noncoding RNA LOC100129940-N Is Upregulated in Papillary Thyroid Cancer and Promotes the Invasion and Progression.
Choy M; Guo Y; Li H; Wei G; Ye R; Liang W; Xiao H; Li Y; Guan H
Int J Endocrinol; 2019; 2019():7043509. PubMed ID: 31093280
[TBL] [Abstract][Full Text] [Related]
55. GAS8 and GAS8-AS1 expression in gastric cancer.
Esfandi F; Mohammad Rezaei F; Taheri M; Naby Gol M; Kholghi Oskooei V; Namvar A; Ghafouri-Fard S
Gastroenterol Hepatol Bed Bench; 2019; 12(4):322-327. PubMed ID: 31749921
[TBL] [Abstract][Full Text] [Related]
56. Pyruvate carboxylase promotes malignant transformation of papillary thyroid carcinoma and reduces iodine uptake.
Liu Y; Liu C; Pan Y; Zhou J; Ju H; Zhang Y
Cell Death Discov; 2022 Oct; 8(1):423. PubMed ID: 36266265
[TBL] [Abstract][Full Text] [Related]
57. The
Pellecchia S; Sepe R; Federico A; Cuomo M; Credendino SC; Pisapia P; Bellevicine C; Nicolau-Neto P; Severo Ramundo M; Crescenzi E; De Vita G; Terracciano LM; Chiariotti L; Fusco A; Pallante P
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31181813
[No Abstract] [Full Text] [Related]
58. Differential expression of Vitamin D binding protein in thyroid cancer health disparities.
Mull B; Davis R; Munir I; Perez MC; Simental AA; Khan S
Oncotarget; 2021 Mar; 12(7):596-607. PubMed ID: 33868582
[TBL] [Abstract][Full Text] [Related]
59. Correction: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
Li J; Zhuang C; Liu Y; Chen M; Chen Y; Chen Z; He A; Lin J; Zhan Y; Liu L; Xu W; Zhao G; Guo Y; Wu H; Cai Z; Huang W
J Exp Clin Cancer Res; 2023 Nov; 42(1):321. PubMed ID: 38012784
[No Abstract] [Full Text] [Related]
60. Correction to: Long non-coding RNA ZMIZ1-AS1 promotes osteosarcoma progression by stabilization of ZMIZ1.
Zhou Y; Jin Q; Chang J; Zhao Z; Sun C
Cell Biol Toxicol; 2023 Dec; 39(6):3341-3343. PubMed ID: 36577867
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
